Start-Up Quarterly Statistics, Q2 2015

23 Sep 2015

• By Deanna Kamienski

Life sciences start-ups raised $2.61 billion in Q2 2015. Biotechs penned 38 alliances; seven acquisitions were signed, none in the medical device industry.

During the second quarter of 2015, start-up companies raised a total of $2.61 billion, $130 million less than last quarter's record-breaking total. Biopharma companies pulled in the majority, an impressive $2.47 billion, 45% resulting from public start-up fundraising (PIPEs, IPOs, follow-ons). Medical device firms raised $70.2 million and in vitro diagnostics companies added $67.7 million.

Exhibit 1